Immuno-Biological Laboratories Co., Ltd. logo

Immuno-Biological Laboratories Co., Ltd. (4570)

Market Open
7 Aug, 06:00
JPX JPX
¥
940. 00
-12
-1.2605%
¥
29.06B Market Cap
- P/E Ratio
7.5% Div Yield
113,700 Volume
- Eps
¥ 952
Previous Close
Add Transaction
Day Range
929 967
Year Range
464 3,820
Want to track 4570 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

4570 trading today lower at ¥940, a decrease of -1.2605% from yesterday's close, completing a monthly decrease of -2.6915% or -¥26. Over the past 12 months, 4570 stock lost -51.0926%.
4570 is not paying dividends to its shareholders.
The last earnings report, released on May 20, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Immuno-Biological Laboratories Co., Ltd. has completed 1 stock splits, with the recent split occurring on Sep 26, 2013.
The company's stock is traded on one exchange.

4570 Chart

People also search for

Fukuda Denshi Co., Ltd.
¥ 12,060
+0.4163%
Pilot Corporation
¥ 1,988.5
-0.8477%
Ain Holdings Inc.
¥ 6,024
+0.8707%
Union Tool Co.
¥ 16,310
-3.4911%
Osg Corporation
¥ 3,832
-1.5163%

Immuno-Biological Laboratories Co., Ltd. (4570) FAQ

What is the stock price today?

The current price is ¥940.00.

On which exchange is it traded?

Immuno-Biological Laboratories Co., Ltd. is listed on JPX.

What is its stock symbol?

The ticker symbol is 4570.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 7.5%.

What is its market cap?

As of today, the market cap is 29.06B.

Has Immuno-Biological Laboratories Co., Ltd. ever had a stock split?

Immuno-Biological Laboratories Co., Ltd. had 1 splits and the recent split was on Sep 26, 2013.

Immuno-Biological Laboratories Co., Ltd. Profile

Biotechnology Industry
Healthcare Sector
- CEO
JPX Exchange
JP3921300004 ISIN
Japan Country
58 Employees
- Last Dividend
26 Sep 2013 Last Split
- IPO Date

Overview

Immuno-Biological Laboratories Co., Ltd., founded in 1982 and headquartered in Fujioka, Japan, is a company at the frontier of the immunological research sector. It specializes in the research, development, manufacturing, and global distribution of various immunological research reagents. The company's mission encompasses supporting cutting-edge research in critical areas such as Alzheimer's disease, metabolic syndrome, and cancer, thereby contributing significantly to the advancement of life sciences and medical research. Immuno-Biological Laboratories also diversifies its offerings through the provision of customized services, ranging from antibody production to the development of specific ELISA (Enzyme-Linked Immunosorbent Assay) systems tailored to the unique requirements of their clients, ensuring a wide-reaching impact across various research fields.

Products and Services

  • ELISA (Enzyme-Linked Immunosorbent Assay) Kits
  • ELISA kits are provided by Immuno-Biological Laboratories as a comprehensive analytical tool designed for the quantitative measurement of targeted substances. These kits are fundamental in facilitating research across an array of domains, including but not limited to the study of diseases such as Alzheimer's and various forms of cancer. The versatility of these kits makes them an essential asset for research laboratories worldwide.

  • LipoSEARCH
  • LipoSEARCH offers a specialized analytical service for the profiling and analysis of lipoproteins using the gel-filtration high-performance liquid chromatography method. This service can analyze tiny clinical samples, including plasma or serum from both small animals and humans, making it invaluable for research in lipid metabolism, drug development for lifestyle-related diseases, the development of functional foods, and clinical studies.

  • LipoTEST
  • LipoTEST is a diagnostic and health check tool utilized in animal clinics, providing a means to support diagnostics and routine health assessments. This service emphasizes the company's commitment to veterinary health care and the role of diagnostics in preventive medicine.

  • Customized Biomarker Testing Services
  • These services are tailored for the detection and analysis of biomarkers related to lifestyle diseases, offering crucial support for clinical research, disease diagnostics, and the development of therapeutic strategies. Immuno-Biological Laboratories leverages its expertise to provide customized biomarker solutions, facilitating significant advancements in healthcare research and diagnostics.

  • Protein Production Using Transgenic Silkworms
  • Immuno-Biological Laboratories utilizes cutting-edge biotechnology in the form of transgenic silkworms for the production of various proteins. This innovative approach serves multiple purposes, including the manufacturing of antibodies for research and diagnostic products, human collagen for cosmetic materials, and proteins for pharmaceutical applications. The use of transgenic silkworms underscores the company’s dedication to employing sustainable and efficient production methods in biotechnology.

Contact Information

Address: Fujioka Laboratory
Phone: 81 2 7422 2889